Realworld safety and patient profile of fingolimod in relapsing-remitting multiple sclerosis: a prospective analysis in Buenos Aires, Argentina

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Clinical neuropharmacology Year:2017 | Volume:40 | Issue:6 Page(s): 251-254

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Realworld safety and patient profile of fingolimod in relapsing-remitting multiple sclerosis: a prospective analysis in Buenos Aires, Argentina

Author(s)

| Issue Writer Certificate

Keywords

Not Registered.

Abstract

Cites

A REVIEW ON FINGOLIMOD; THE FIRST ORAL MEDICATION FOR MULTIPLE SCLEROSIS

References

No record.

Cite

APA: Copy

. (2017). Realworld safety and patient profile of fingolimod in relapsing-remitting multiple sclerosis: a prospective analysis in Buenos Aires, Argentina. Clinical neuropharmacology, 40(6), 251-254. SID. https://sid.ir/paper/737495/en

Vancouver: Copy

. Realworld safety and patient profile of fingolimod in relapsing-remitting multiple sclerosis: a prospective analysis in Buenos Aires, Argentina. Clinical neuropharmacology[Internet]. 2017;40(6):251-254. Available from: https://sid.ir/paper/737495/en

IEEE: Copy

, “Realworld safety and patient profile of fingolimod in relapsing-remitting multiple sclerosis: a prospective analysis in Buenos Aires, Argentina,” Clinical neuropharmacology, vol. 40, no. 6, pp. 251–254, 2017, [Online]. Available: https://sid.ir/paper/737495/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops